Use of a novel high-osmolar gadolinium chelate, gadobutrol, for percutaneous renal artery stenting in two patients with chronic renal failure

Carlo Trani, Francesco Burzotta, Filippo Crea, Elisa Romagnoli, Francesca Augusta Gabrielli, Antonio Abbate, Flavia Belloni, Giovanni Schiavoni, Mario Attilio Mazzari, Francesca A. Gabrielli

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Gadolinium chelates have been recently proposed and preliminarily tested as contrast agents for diagnostic and interventional angiography in alternative to iodinated media. However, in most studies low-osmolarity agents were employed and digital subtraction was required for satisfactory images. In this article, we report for the first time in the literature two cases of successful percutaneous renal artery stenting in which gadobutrol, a high-osmolar (1 mmol/ml) gadolinium chelate, was employed as contrast agent because of chronic renal failure and substantial risk for iodinated contrast-associated nephrotoxicity. In both patients gadobutrol yielded high-quality images without digital subtraction and was well tolerated with no ensuing renal dysfunction.
Original languageEnglish
Pages (from-to)361-362
Number of pages2
JournalINTERNATIONAL JOURNAL OF CARDIOLOGY
Volume102
DOIs
Publication statusPublished - 2005

Keywords

  • Gadolinium
  • Renal failure
  • Renovascular hypertension
  • Stent

Fingerprint Dive into the research topics of 'Use of a novel high-osmolar gadolinium chelate, gadobutrol, for percutaneous renal artery stenting in two patients with chronic renal failure'. Together they form a unique fingerprint.

Cite this